An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

An evaluation of the combination of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis

Published:2023-01-02 Issue:1 Volume:23 Page:1-7
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Sun Yuyao¹,Li Xiaoyan²,Bedlack Richard²

Affiliation:

1. Department of Neurology, University of Kentucky, Lexington, KY, USA

2. Department of Neurology, Duke University, Durham, NC, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2023.2174018

Reference27 articles.

1. Amyotrophic Lateral Sclerosis

2. The epidemiology of motor neuron diseases: a review of recent studies

3. Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997-2011 - PubMed [Internet]. [cited 2022 Nov 12]. Available from: https://pubmed.ncbi.nlm.nih.gov/24195020/.

4. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature

5. Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6 inhibition as a mechanism to prevent neurodegeneration in the mSOD1G93A mouse model of ALS;Heliyon;2024-07

2. New insights into sodium phenylbutyrate as a pharmacotherapeutic option for neurological disorders;Synapse;2024-05-31

3. Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration;International Journal of Molecular Sciences;2024-05-21

4. Capitalizing on Hope: Questionable Marketing Approval and Pricing of a New ALS Drug;International Journal of Social Determinants of Health and Health Services;2024-04-22

5. Synthetic Approaches to the New Drugs Approved During 2022;Journal of Medicinal Chemistry;2024-03-15